The regulatory approvals in Indonesia and the Philippines represent significant market expansion opportunities. The demonstrated clinical adoption (150+ telesurgeries) and upcoming conference showcasing live procedures suggest growing momentum that could accelerate commercialization and revenue generation.
Price Chart
Executive Summary
SS Innovations announced regulatory approval for its SSi Mantra surgical robotic system to perform telesurgeries in Indonesia and the Philippines, and reported surpassing 150 cumulative telesurgeries performed primarily in India. The company also announced plans to host the Global Multi-Specialty Robotic Surgery Conference 2026 in New Delhi.
Key Facts
- SSi Mantra surgical robotic system approved for telesurgeries in Indonesia and the Philippines
- Company has performed over 150 cumulative telesurgeries with the SSi Mantra system, primarily in India
- Recent demonstration included 18 inter-hospital telesurgeries in an eight-hour period
- Company to host Global Multi-Specialty Robotic Surgery Conference 2026 in New Delhi from April 9-11, 2026, featuring over 20 live telesurgeries
- SSi Mantra system features portable SSi MantrAsana Tele Surgeon Console enabling telesurgeries from various settings
Financial Impact
Positive expansion into two new international markets with potential for revenue growth from system sales and procedures
Risk Factors
- Regulatory approvals do not guarantee commercial adoption or reimbursement
- Execution risk in scaling operations in new international markets
- Competition from established surgical robotics companies
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-029907 |
| Document: ea028225301ex99-1.htm | 0001213900-26-029907 |
| Document: 0001213900-26-029907-index-headers.html | 0001213900-26-029907 |
| Document: 0001213900-26-029907-index.html | 0001213900-26-029907 |
| Document: 0001213900-26-029907.txt | 0001213900-26-029907 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+5 | — | — |
Oct 26, 2026 today | Press Release | — | awaiting T+5 | — | — |
Oct 13, 2026 13d ago | 8-K | $2.55 $2.54 | ▼ −0.39% | ▲ +0.76% | $2.37 (−7.06%) |
Oct 13, 2026 13d ago | 8-K | $2.55 $2.54 | ▲ +0.39% | ▼ −0.76% | $2.37 (+7.06%) |
Oct 9, 2026 17d ago | 424B5 | $2.55 $2.45 | ▲ +3.92% | ▲ +2.43% | $2.37 (+7.06%) |
Oct 5, 2026 21d ago | 8-K | $2.77 $2.55 | ▼ −7.94% | ▼ −8.36% | $2.37 (−14.44%) |
Sep 10, 2026 6w ago | 8-K | $3.30 $3.26 | ▼ −1.21% | ▼ −0.71% | $2.37 (−28.18%) |
Aug 13, 2026 10w ago | 8-K | $3.83 $3.61 | ▼ −5.74% | ▼ −3.78% | $2.37 (−38.12%) |
Jul 17, 2026 14w ago | 8-K | $3.64 $3.57 | ▼ −1.92% | ▼ −1.24% | $2.37 (−34.89%) |
Jul 14, 2026 14w ago | 8-K | $3.67 $3.75 | ▲ +2.18% | ▲ +3.48% | $2.37 (−35.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers